LoadingWorld Markets / China STAR 50 /
Last close 82.44000244 on 2026-11-02
Founded: 2004
Founders: Du Jinhao, Guo Jianhui
Allist Pharmaceuticals is a Shanghai drug developer whose core product is furmonertinib, an EGFR inhibitor approved in China for non-small cell lung cancer. It listed on the Shanghai STAR Market on 2 December 2020.
